Sulfur dioxide has recently been found to be produced endogenously in the cardiovascular system and have important positive
biological effects. However, it is unknown whether
sulfur dioxide preconditioning has a protective effect on rat
myocardial ischemia/reperfusion (I/R) injury and whether this process involves endoplasmic reticulum stress (ERS). In this study, we showed that preconditioning with
sulfur dioxide 10 min before
ischemia (with a low concentration of
sulfur dioxide of 1-10 μmol/kg) could reduce
myocardial infarct size and plasma activities of
lactate dehydrogenase and
creatine kinase in rats with I/R in vivo.
Sulfur dioxide preconditioning also reduced myocardium apoptosis induced by I/R. In addition,
sulfur dioxide preconditioning increased cardiac function in vitro.
Sulfur dioxide preconditioning induced expression of myocardial
glucose-regulated
protein 78 (
GRP78) and phosphorylated eukaryotic initiation of the factor 2α-subunit (p-eIF2α) prior to myocardial I/R but suppressed expression of myocardial
GRP78,
C/EBP homologous protein, and p-eIF2α during myocardial I/R, in association with improved myocardial injury in vivo and in vitro. Pretreatment with
dithiothreitol, an ERS stimulator mimicked the above cardioprotective effect. However, pretreatment with the ERS inhibitor
4-phenylbutyrate reversed the cardioprotection provided by
sulfur dioxide preconditioning. These data indicated that
sulfur dioxide preconditioning reduced I/R-induced myocardial injury in vivo and in vitro, and that augmenting ERS by
sulfur dioxide preconditioning prior to I/R contributed to protection against myocardial I/R injury.